MK0524

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK0524, covering 2015-10-16 to 2015-12-22. Get the full timeline:

Most recent: Clinical Trial Update: MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) [Phase 2]